Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 7/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.57 |
| ▸ | FAAH | O00519 | 5/20 | 0.57 |
| ▸ | MGLL | Q99685 | 3/20 | 0.57 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.50 |
| ▸ | CASP2 | P42575 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17345175 | 0.94 | PTGS1 (0.51) | PTGS1PTGS2FAAHMGLLCASP2 | |
| SCHEMBL20151750 | 0.92 | MGLL (0.63) | FAAHMGLLTRPV1MEN1MAPT | |
| SCHEMBL17740192 | 0.91 | PTGS1 (0.63) | PTGS1PTGS2FAAHMGLLDNM1 | |
| SCHEMBL12146983 | 0.91 | PTGS1 (0.63) | PTGS1PTGS2FAAHMGLLDNM1 | |
| SCHEMBL17740190 | 0.91 | PTGS1 (0.63) | PTGS1PTGS2FAAHMGLLDNM1 | |
| SCHEMBL22295467 | 0.90 | FAAH (0.47) | PTGS1PTGS2FAAHMGLLDNM1 | |
| SCHEMBL15739654 | 0.90 | PTGS1 (0.60) | PTGS1PTGS2FAAHMGLLDNM1 | |
| SCHEMBL19703875 | 0.90 | PTGS1 (0.60) | PTGS1PTGS2FAAHMGLLDNM1 | |
| SCHEMBL19380535 | 0.90 | PTGS1 (0.60) | PTGS1PTGS2FAAHMGLLDNM1 | |
| SCHEMBL15613431 | 0.88 | PTGS1 (0.57) | PTGS1PTGS2FAAHMGLLDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11857638-B2 | Quinone-containing conjugates | PROMEGA CORPORATION (US) | 2024-01-02 | — | — | US | disclosed |
| US-20220249438-A1 | CARBOCYANINE COMPOUNDS FOR TARGETING MITOCHONDRIA AND ERADICATING CANCER STEM CELLS | LUNELLA BIOTECH, INC. (CA) | 2022-08-11 | — | — | US | disclosed |
| US-20200030456-A1 | QUINONE-CONTAINING CONJUGATES | PROMEGA CORPORATION | 2020-01-30 | — | — | US | disclosed |
| US-20170158858-A9 | CYANINE COMPOUNDS | PIERCE BIOTECHNOLOGY, INC. | 2017-06-08 | — | — | US | disclosed |
| US-20170114038-A9 | CYANINE COMPOUNDS | PIERCE BIOTECHNOLOGY, INC. | 2017-04-27 | — | — | US | disclosed |
| US-9631096-B2 | Dye compositions, methods of preparation, conjugates thereof, and methods of use | CORNELL UNIVERSITY (US) | 2017-04-25 | — | — | US | disclosed |
| US-20160176852-A1 | CYANINE COMPOUNDS | HERMANSON GREG (US) | 2016-06-23 | — | — | US | disclosed |
| US-20160168383-A1 | CYANINE COMPOUNDS | HERMANSON GREG (US) | 2016-06-16 | — | — | US | disclosed |
| US-20150011731-A1 | DYE COMPOSITIONS, METHODS OF PREPARATION, CONJUGATES THEREOF, AND METHODS OF USE | CORNELL UNIVERSITY (US) | 2015-01-08 | — | — | US | disclosed |
| US-20140255312-A1 | CYANINE COMPOUNDS | PIERCE BIOTECHNOLOGY, INC. | 2014-09-11 | — | — | US | disclosed |
| US-20140072515-A9 | CYANINE COMPOUNDS | PIERCE BIOTECHNOLOGY, INC. | 2014-03-13 | — | — | US | disclosed |
| US-20130251637-A9 | FLUORESCENT COMPOUNDS | DYOMICS GMBH (DE) | 2013-09-26 | — | — | US | disclosed |
| US-20130230466-A1 | CYANINE COMPOUNDS | HERMANSON GREG (US) | 2013-09-05 | — | — | US | disclosed |
| US-8426618-B2 | Luminescence quenching compounds | ANASPEC INCORPORATED (US) | 2013-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170158858-A9 | CYANINE COMPOUNDS | NCL, NOP58, NAT10 | PTGS1 4766/4885PTGS2 4738/4885FAAH 4365/4885 |
| US-20200030456-A1 | QUINONE-CONTAINING CONJUGATES | NQO1, NQO2, SQOR | PTGS1 2095/4885PTGS2 2098/4885FAAH 3232/4885 |
| US-20220249438-A1 | CARBOCYANINE COMPOUNDS FOR TARGETING MITOCHONDRIA AND ERADICATING CANCER STEM CELLS | UQCRC1, MT-CO2, UQCRC2 | PTGS1 2713/4885PTGS2 2501/4885FAAH 4790/4885 |
| US-20140255312-A1 | CYANINE COMPOUNDS | NCL, NOP58, NAT10 | PTGS1 4766/4885PTGS2 4738/4885FAAH 4365/4885 |
| US-20170114038-A9 | CYANINE COMPOUNDS | NCL, NOP58, NAT10 | PTGS1 4766/4885PTGS2 4738/4885FAAH 4365/4885 |
| US-20130230466-A1 | CYANINE COMPOUNDS | NCL, NOP58, NAT10 | PTGS1 4766/4885PTGS2 4738/4885FAAH 4365/4885 |
| US-20160176852-A1 | CYANINE COMPOUNDS | NCL, NOP58, NAT10 | PTGS1 4766/4885PTGS2 4738/4885FAAH 4365/4885 |
| US-20130251637-A9 | FLUORESCENT COMPOUNDS | NCL, FUS, EFTUD2 | PTGS1 4228/4885PTGS2 4278/4885FAAH 3454/4885 |
| US-11857638-B2 | Quinone-containing conjugates | NQO1, NQO2, SQOR | PTGS1 2095/4885PTGS2 2098/4885FAAH 3232/4885 |
| US-20160168383-A1 | CYANINE COMPOUNDS | NCL, NOP58, NAT10 | PTGS1 4766/4885PTGS2 4738/4885FAAH 4365/4885 |
| US-20140072515-A9 | CYANINE COMPOUNDS | NCL, NOP58, NAT10 | PTGS1 4766/4885PTGS2 4738/4885FAAH 4365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.